Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

HanAll Biopharma Announces Orphan Drug Designation for Batoclimab in Japan for Active Thyroid Eye Disease

PR NewswireMarch 17, 2025

Tag: HanAll Biopharma , ODD , Batoclimab , eye disease

PharmaSources Customer Service